Short-term histopathologic effects of different intracavernosal agents on corpus cavernosum and antifibrotic activity of intracavernosal verapamil: an experimental study
Authors:
- M.Murat BaŞarMBM.Murat BaŞar
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Clinical Experience with Intraurethral Alprostadil (MUSE®) in the Treatment of Men with Erectile DysfunctionEuropean Urology, 2000
- Comparative Tolerability and Efficacy of Treatments for ImpotenceDrug Safety, 1999
- Long-term follow-up of patients receiving injection therapy for erectile dysfunctionUrology, 1997
- ORAL AND TOPICAL TREATMENT OF ERECTILE DYSFUNCTIONUrologic Clinics of North America, 1995
- Pharmacological Management of Erectile DysfunctionDrugs, 1995
- Intralesional Verapamil Injection for the Treatment of Peyronie’s DiseaseJournal of Urology, 1994
- Nitric oxide synthase: A new diagnostic tool for neurogenic impotenceUrology, 1993
- Impotence Evaluated by the Use of Prostaglandin E1Journal of Urology, 1989
- Intracavernous Injection of Prostaglandin E1 in Impotent MenJournal of Urology, 1988
- INTRACAVERNOUS INJECTION OF PAPAVERINE FOR ERECTILE FAILUREThe Lancet, 1982